Hepatitis c inhibitor compounds

Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.

Saved in:
Bibliographic Details
Main Authors BORDELEAU, JOSEE, BHARDWAJ, PUNIT, HALMOS, TEDDY, LLINAS-BRUNET, MONTSE, FORGIONE, PASQUALE, GOUDREAU, NATHALIE, GORYS, VIDA, J, GOULET, SYLVIE, RANCOURT, JEAN, BAILEY, MURRAY, D, GHIRO, ELISE
Format Patent
LanguageEnglish
Published 28.02.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of formula (I): wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
Bibliography:Application Number: ZA20050008201